Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol

Stopped Nationwide shortage of study meds in 2013 loss of funding \& competing studies

Conditions

• Kidney Failure
• Secondary Hyperparathyroidism
• Hyperphosphatemia
• Hypercalcemia

Interventions

• DRUG: Calcitriol
• DRUG: Paricalcitol

Sponsor

Winthrop University Hospital